↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"

A　B　C　D　E　F　G　H　 I 　J　K　L　M　N　O　P　Q　R　S　T　U　V　W　X　Y　Z　other

122 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名（臨床試験情報から抽出）   DrugBank   KEGG DRUG *   KEGG GENES *   KEGG PATHWAY   指定難病告示番号 * 
 1   2% sodium chondroitin sulfate   Chondroitin sulfate   D00080   -   -   1件:
226 
 2   5% lidocaine/5 mg/ml estradiol compound cream   Estradiol, Lidocaine   D00105, D00358, D01413, D01617, D01953, D02086, D04061, D04063, D04064, D04065, D08127   7件: ESR1, ESR2, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   12件: Adrenergic signaling in cardiomyocytes, Breast cancer, Dopaminergic synapse, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Taste transduction, Thyroid hormone signaling pathway   1件:
226 
 3   Adalimumab   Adalimumab   D02597   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   15件:
19,
37,
41,
46,
56,
84,
96,
97,
151,
160,
164,
222,
226,
269,
271 
 4   Agn 203818   -   -   -   -   1件:
226 
 5   Alkalinized lidocaine-heparin   Lidocaine   D00358, D02086, D08127   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   1件:
226 
 6   Amitriptyline   Amitriptyline   D00809, D07448   2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   3件:
78,
226,
299 
 7   Aqx-1125   -   -   -   -   1件:
226 
 8   Aqx-1125 100 mg   -   -   -   -   1件:
226 
 9   Aqx-1125 200 mg   -   -   -   -   1件:
226 
 10   Asp3652   -   -   -   -   1件:
226 
 11   Asp6294   -   -   -   -   1件:
226 
 12   Bladder instillation with heparin/ lidocaine   Lidocaine   D00358, D02086, D08127   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   1件:
226 
 13   Bladder instillation with triamcinolone acetonide   Triamcinolone   D00385, D00983, D00984, D00985, D06216   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
226 
 14   Bladder instillation without triamcinolone acetonide   Triamcinolone   D00385, D00983, D00984, D00985, D06216   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
226 
 15   Bladder instillations   -   -   -   -   1件:
226 
 16   Botox   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   4件:
6,
13,
149,
226 
 17   Botox 200u in normal saline   -   -   -   -   1件:
226 
 18   Botulinum toxin a   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   4件:
13,
51,
149,
226 
 19   Buckwheat   Buckwheat   -   -   -   1件:
226 
 20   Bupivacaine   Bupivacaine   D01450, D07552   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   7件:
46,
53,
70,
96,
168,
226,
298 
 21   Capsaicin   Capsaicin   D00250   1件: TRPV1   2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   6件:
2,
6,
19,
86,
113,
226 
 22   Certolizumab pegol   Certolizumab pegol   D03441   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   6件:
37,
46,
96,
97,
226,
271 
 23   Chondroitin sulfate   Chondroitin sulfate   D00080   -   -   2件:
96,
226 
 24   Ciclosporin   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   13件:
26,
46,
49,
50,
53,
55,
60,
61,
97,
222,
226,
228,
269 
 25   Ciklosporin   -   -   -   -   1件:
226 
 26   Cyclosporine   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   33件:
11,
14,
19,
20,
28,
36,
40,
41,
42,
45,
46,
49,
50,
53,
56,
58,
60,
62,
64,
65,
90,
95,
97,
162,
164,
222,
226,
228,
234,
283,
284,
285,
302 
 27   Dexmedetomidine   Dexmedetomidine   D00514, D01205   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   11件:
2,
4,
6,
21,
34,
70,
113,
212,
215,
226,
280 
 28   Dimethyl sulfoxide   Dimethyl sulfoxide   D01043   -   -   1件:
226 
 29   Dmso   Dimethyl sulfoxide   D01043   -   -   1件:
226 
 30   Dmso cocktail   Dimethyl sulfoxide   D01043   -   -   1件:
226 
 31   Erb-041   -   -   -   -   3件:
46,
96,
226 
 32   Estradiol   Estradiol   D00105, D01413, D01617, D01953, D04061, D04063, D04064, D04065   2件: ESR1, ESR2   9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway   5件:
13,
46,
49,
226,
299 
 33   Fospropofol   Fospropofol   D04257   -   -   1件:
226 
 34   Fospropofol (lusedra®) 10   Fospropofol   D04257   -   -   1件:
226 
 35   Fospropofol (lusedra®) 12   Fospropofol   D04257   -   -   1件:
226 
 36   Fospropofol (lusedra®) 6.5   Fospropofol   D04257   -   -   1件:
226 
 37   Gefapixant   Gefapixant   D11349   1件: P2RX3   3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Taste transduction   2件:
85,
226 
 38   Glycine   Glycine   D00011   -   -   4件:
35,
86,
226,
299 
 39   Gralise   Gabapentin   D00332   5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1   9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), GABAergic synapse, Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle   2件:
97,
226 
 40   Heparin   Heparin   D07510   1件: SERPINC1   1件: Complement and coagulation cascades   11件:
60,
70,
79,
84,
107,
224,
226,
280,
299,
316,
317 
 41   Hyaluronic acid   Hyaluronic acid   D08043   -   -   5件:
46,
53,
70,
226,
231 
 42   Hyaluronic acid and chondroitin sulfate   Chondroitin sulfate   D00080   -   -   1件:
226 
 43   Hyaluronic acid/chondroitin sulfate   Chondroitin sulfate   D00080   -   -   1件:
226 
 44   Hydrogen   Hydrogen   -   -   -   5件:
5,
6,
17,
97,
226 
 45   Ic cocktail   -   -   -   -   1件:
226 
 46   Intravesical onabotulinumtoxina injection   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   1件:
226 
 47   Ipd® (japanese tradename)   -   -   -   -   1件:
226 
 48   Ketorolac   Ketorolac   D00813, D08104   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   2件:
70,
226 
 49   Ketorolac tromethamine   Tromethamine   D00396   -   -   1件:
226 
 50   Krp-116d   -   -   -   -   1件:
226 
 51   Lidocaine   Lidocaine   D00358, D02086, D08127   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   8件:
6,
13,
46,
86,
168,
226,
231,
256 
 52   Lidocaine releasing intravesical system - liris®   Lidocaine   D00358, D02086, D08127   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   1件:
226 
 53   Liposome encapsulated bont-a   -   -   -   -   1件:
226 
 54   Liposomes   -   -   -   -   1件:
226 
 55   Liris 400 mg   -   -   -   -   1件:
226 
 56   Liris low dose and liris high dose   -   -   -   -   1件:
226 
 57   Liris®   -   -   -   -   1件:
226 
 58   Liris® 400 mg   -   -   -   -   1件:
226 
 59   Lp-08 20mg   -   -   -   -   1件:
226 
 60   Lp-08 80mg   -   -   -   -   1件:
226 
 61   Metoprolol   Metoprolol   D00601, D02358, D05011   1件: ADRB1   10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   6件:
17,
57,
58,
113,
193,
226 
 62   Metoprolol tartrate oral tablet   Metoprolol   D00601, D02358, D05011   1件: ADRB1   10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
226 
 63   Mirabegron   Mirabegron   D09535   1件: ADRB3   7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway   3件:
6,
13,
226 
 64   Mn-001   -   -   -   -   1件:
226 
 65   Mn-001 bid   -   -   -   -   1件:
226 
 66   Mycofenolate mofetil (mmf)   -   -   -   -   1件:
226 
 67   Mycophenolate   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   33件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 68   Mycophenolate mofetil   Mycophenolate mofetil   D00752, D05094, D05095   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   32件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 69   Naloxone   Naloxone   D01340, D08249   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   2件:
6,
226 
 70   Naloxone hydrochloride   Naloxone   D01340, D08249   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   1件:
226 
 71   Normal saline   -   -   -   -   14件:
6,
17,
22,
36,
46,
49,
60,
94,
96,
211,
226,
276,
296,
299 
 72   Normal saline instillation   -   -   -   -   1件:
226 
 73   Nortriptyline   Nortriptyline   D00816, D08288   2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   2件:
6,
226 
 74   Omalizumab   Omalizumab   D05251   1件: FCER1A   4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway   6件:
53,
65,
98,
162,
226,
299 
 75   Onabotulinumtoxin a   -   -   -   -   1件:
226 
 76   Onabotulinumtoxina   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   3件:
6,
13,
226 
 77   Oxn 10/5 mg pr   -   -   -   -   1件:
226 
 78   Oxn 20/10 mg pr   -   -   -   -   1件:
226 
 79   Oxn 5/2.5 mg pr   -   -   -   -   1件:
226 
 80   Oxycodone   Oxycodone   D03783, D05312, D05462   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   7件:
6,
13,
46,
70,
226,
231,
298 
 81   Oxycodone hydrochloride   Oxycodone   D03783, D05312, D05462   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   3件:
70,
226,
298 
 82   Oxycodone naloxone prolonged release tablets   Oxycodone   D03783, D05312, D05462   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   1件:
226 
 83   Oxycodone/naloxone prolonged release t   Oxycodone   D03783, D05312, D05462   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   1件:
226 
 84   Oxycodone/naloxone prolonged release tablets 10/5 mg   Oxycodone   D03783, D05312, D05462   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   1件:
226 
 85   Oxycodone/naloxone prolonged release tablets 20/10 mg   Oxycodone   D03783, D05312, D05462   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   1件:
226 
 86   Oxycodone/naloxone prolonged release tablets 5/2.5 mg   Oxycodone   D03783, D05312, D05462   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   1件:
226 
 87   Oxygen   Oxygen   D00003   -   -   14件:
46,
49,
70,
84,
85,
86,
88,
90,
96,
97,
193,
226,
299,
330 
 88   Oxytocin   Oxytocin   D00089   1件: OXTR   4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway   4件:
127,
193,
206,
226 
 89   Pd 0299685   -   -   -   -   1件:
226 
 90   Pd 0299685 at 15mg bid   -   -   -   -   1件:
226 
 91   Pd 0299685 at 30mg bid   -   -   -   -   1件:
226 
 92   Pentosan polysulfate   Pentosan polysulfate   D05428   -   -   3件:
19,
26,
226 
 93   Pentosan polysulfate sodium 100 mg   Pentosan polysulfate   D05428   -   -   1件:
226 
 94   Pf-04383119   -   -   -   -   1件:
226 
 95   Placebo   -   -   -   -   20件:
3,
6,
13,
14,
40,
46,
49,
50,
51,
66,
67,
79,
85,
86,
88,
96,
97,
144,
149,
226 
 96   Platelet enriched plasma   -   -   -   -   1件:
226 
 97   Platelet-rich plasma   -   -   -   -   1件:
226 
 98   Prograf   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   3件:
60,
222,
226 
 99   Propiverine   Propiverine   D08441   9件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   40件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy (DCM), Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy (HCM), Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
226 
 100   Propiverine hydrochloride   Propiverine   D08441   9件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   40件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy (DCM), Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy (HCM), Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
226 
 101   Rimso   Dimethyl sulfoxide   D01043   -   -   1件:
226 
 102   Rimso 50   Dimethyl sulfoxide   D01043   -   -   1件:
226 
 103   Rn624, ri624   -   -   -   -   1件:
226 
 104   Sandimmun   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   4件:
53,
60,
113,
226 
 105   Sandimmun neoral   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   2件:
60,
226 
 106   Sildenafil   Sildenafil   D02229, D08514   1件: PDE5A   3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway   15件:
6,
46,
50,
51,
85,
86,
113,
210,
211,
212,
225,
226,
278,
294,
299 
 107   Sugar pill   -   -   -   -   7件:
6,
49,
67,
70,
86,
206,
226 
 108   Sulfate   Sulfate ion   -   -   -   22件:
2,
6,
11,
13,
26,
34,
36,
46,
49,
60,
61,
64,
66,
79,
86,
96,
222,
226,
265,
296,
297,
299 
 109   Suplatast tosilate   -   -   -   -   1件:
226 
 110   Tacrolimus   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   29件:
2,
11,
13,
36,
46,
49,
50,
51,
53,
60,
61,
62,
65,
66,
85,
95,
96,
97,
113,
151,
158,
164,
222,
224,
226,
228,
283,
284,
299 
 111   Tanezumab   Tanezumab   D09387   1件: NGF   8件: Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway   2件:
226,
298 
 112   Targinact 10 mg/5 mg prolonged-release tablets   -   -   -   -   1件:
226 
 113   Targinact 20mg/10 mg prolonged-release tablets   -   -   -   -   1件:
226 
 114   Targinact 5mg/2.5 mg prolonged-release tablets   -   -   -   -   1件:
226 
 115   Tramadol   Tramadol   D01355, D08623   1件: OPRM1   3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction   5件:
46,
70,
78,
226,
271 
 116   Triamcinolone   Triamcinolone   D00385, D00983, D00984, D00985, D06216   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   8件:
35,
46,
56,
70,
90,
96,
226,
298 
 117   Tromethamine   Tromethamine   D00396   -   -   1件:
226 
 118   Tti-1612   -   -   -   -   1件:
226 
 119   Urg101   -   -   -   -   1件:
226 
 120   Water   Water   D00001   -   -   18件:
2,
5,
6,
13,
17,
19,
35,
46,
53,
57,
63,
65,
67,
84,
97,
226,
278,
299 
 121   Ym672   -   -   -   -   1件:
226 
 122   Ym672 (ipd®)   -   -   -   -   1件:
226 

先頭へ